Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-Year experience

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 1, 1999, Pages 13-19

  Meythaler, Jay M ^a,b   Guin Renfroe, Sharon ^a   Grabb, Paul ^a   Hadley, Mark N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTINUOUS INFUSION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DYSTONIA; FEMALE; HUMAN; INFUSION PUMP; MALE; MUSCLE HYPERTONIA; SCHOOL CHILD; SPASTICITY;

EID: 0032934282     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90301-5     Document Type: Article

References (49)

1. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity: a prospective study. Am J Phys Med Rehabil 1992;71:321-7.
2. Meythaler JM, Steers WD, Tuel SM, Sesco DV, Haworth CS. Use of intrathecal baclofen in familial spastic paraparesis. Arch Phys Med Rehabil 1992;73:794-7.
3. Albright LA, Meythaler JM, Ivanhoe CB. Intrathecal baclofen therapy for spasticity of cerebral origin: patient selection guidelines. Minneapolis (MN): Medtronics, Inc.; 1997.
4. Katz RT. Mechanisms, measurement, and management of spastic hypertonia after head injury. Phys Med Clin North Am 1992;3: 319-35.
5. Young RR, Delwaide PJ. Spasticity (part one of two parts). N Engl J Med 1981;304:28-33.
6. Young RR, Delwaide PJ. Spasticity (part two of two parts). N Engl J Med 1981;304:96-9.
7. Bullock R, Chestnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, et al. Guidelines for the management of severe head injury: a joint initiative of the American Association of Neurological Surgeons & The Brain Injury Foundation. San Francisco (CA), Brain Trauma Foundation, Inc; 1995.
8. Ashby P, Verrier M, Lightfoot E. Segmental reflex pathways in spinal shock and spinal spasticity in man. J Neurol Neurosurg Psychiatry 1974;37:1352-60.
9. Adams RD, Victor M, editors. Principles of neurology. 5th ed. New York: McGraw-Hill, Inc.; 1993.
10. Mann NH. Functional management of spasticity after head injury. J Neurol Rehabil 1991;5:51-4.
11. Meythaler JM, DeVivo MJ, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996;77:461-6.
12. Meythaler JM. Pharmacology update: intrathecal baclofen for spastic hypertonia in brain injury. J Head Trauma Rehabil 1997;12:87-90.
13. Albright LA, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-7.
14. Ford B, Green P, Louis ED, Petzinger G, Bressman SB, Goodman R, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol 1996;53:1241-6.
15. Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler JM, et al (The Intrathecal Baclofen Multicenter Study Group). Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226-32.
16. Hattab JR. Review of European clinical trials with baclofen. In: Feldman RG, Young RR, Kiella WP, editors. Spasticity. Disordered motor control. Chicago: Year Book Medical Publishers; 1980. p. 71-5.
17. MacDonell RAL, Talolla A, Swash M, Grundy D. Intrathecal baclofen and the H-reflex. J Neurol Neurosurg Psychiatry 1989;52:1110-2.
18. Terrence DV, Fromm GH. Complications of baclofen withdrawal. Arch Neurol 1981;38:588-9.
19. Wilson PR, Yaksh TL. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 1978;51:323-30.
20. Yaksh TL, Ramana Reddy SV. Studies in the primate on the analgetic effects associated with intrathecal actions of opiate, L-adrenergic agonists and baclofen. Anesthesiology 1981;54:451-67.
21. Kroin JS, Penn RD, Beissinger RL, Arzbaecher RC. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 1984;54:191-4.
22. Lazorthes Y, Sallerin-Caute B, Verdie J, Bastide R, Carillo J. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
23. Muller H, Zierski J, Dralle D, Krauss D, Mutschler E. Pharmacokinetics of intrathecal baclofen. In: Muller H, Zierski J, Penn RD, editors. Local-spinal therapy of spasticity. Berlin: Springer-Verlag; 1988. p. 223-6.
24. Penn RD, Savoy SM, Corcos DM, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-22.
25. Meythaler JM, Hadley M, McCary A. Prospective study on the use of continuously infused intrathecal baclofen for spasticity due to acquired brain injury: A preliminary report. J Neurosurg 1997;87:415-9.
26. Kroin JS, Penn RD. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWF, editors. Parenteral drug therapy in spasticity and Parkinson's disease. Canforth, United Kingdom: Parthenon Publishing; 1991. p. 73-83.
27. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997;244:160-6.
28. Akman MN, Loubser MB, Donovan WH, O'Neil ME, Rossi CD. Intrathecal baclofen: does tolerance occur? Paraplegia 1993;31:516-20.
29. O'Dell MW, Bell KR, Sandel ME. Brain injury rehabilitation. 2. Medical rehabilitation of brain injury. Arch Phys Med Rehabil 1998;79 Suppl 1:S10-5.
30. Sokol RR, Rohlf FJ. Biometry. San Francisco (CA): W. H. Freeman; 1969.
31. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.
32. Lee KC, Carson L, Kinnin E, Patterson V. The Ashworth scale: a reliable and reproducible method of measuring spasticity. J Neurol Rehabil 1989;3:205-9.
33. Sabbe MB, Grafe MR, Pfiefer BL, Mirzai THM, Yalish TL. Toxicology of baclofen continuously infused into the spinal intrathecal space of the dog. Neurotoxicology 1993;14:397-410.
34. Klockgether T, Schwarz M, Wullner U, Turski L, Sontag KH. Myorelaxant effect after intrathecal injection of antispastic drugs in rats. Neurosci Lett 1989;97:221-6.
35. Mendell LM. Modifiability of spinal synapses. Physiol Rev 1984;64:260-324.
36. Wilson PR, Yaksh TL. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 1978;51:323-30.
37. Katz R, Pierrot-Deseilligny E. Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions. Brain 1982;105:103-24.
38. Shemesh Y, Rozin R, Ohry A. Electrodiagnostic investigation of motor neuron and spinal reflex arch (H-reflex) in spinal cord injury. Paraplegia 1977;15:238-44.
39. Sandy KR, Gillman MH. Baclofen-induced memory impairment. Clin Neuropharmacol 1985;8:294-5.
40. Roy CW, Wakefield IR. Baclofen pseudopsychosis: case report. Paraplegia 1986;24:318-21.
41. Knuttson E, Lindblom U, Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci 1974;23:473-84.
42. Katz RT. Management of spasticity. Am J Phys Med Rehabil 1988;67:108-16.
43. Meythaler JM, Guin-Renfro S, Hadley M. Continuously infused intrathecal baclofen (ITB) for spastic-hypertonia in adult cerebral palsy [abstract]. Am J Phys Med Rehabil 1998;77:173.
44. Meythaler JM, McCary A, Hadley MN. Intrathecal baclofen for spastic hypertonia in adult brain injury. Perspect Neurosurg 1996;7:99-107.
45. Frost F, Nanninga J, Penn R, Savoy S, Wu Y. Intrathecal baclofen infusion. Effect on bladder management programs in patients with myelopathy. Am J Phys Med and Rehabil 1989;68:112-5.
46. Bushman W, Steers WD, Meythaler JM. Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen. Neurol Urodyn 1993;12:163-70.
47. Steers WD, Meythaler JM, Haworth CS, Park TS. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 1992;148:1849-55.
48. Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebault JB, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 1998;79:494-6.
49. Gerstzen PC, Albright AL, Johnston GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998;88:1009-13.